Cough Suppressant Drugs Market, by Disease Type (Dry Cough and Wet Cough), by Drug Type (Dextromethorphan, Codeine, Noscapine, Butamirate, Benzonatate, Pholcodine, and Others), by Product Type (Over-the-counter (OTC) and Prescription Drug), by Age Group (Pediatric and Adult), by Dosage Form (Syrup, Tablet, and Others), by Distribution Channel (Hospital, Retail Pharmacy, Online Pharmacy, and Others), and Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

  • Published On : Jan 2019 |
  • Pages : 175 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Cough Suppressant Drugs Market- Insights

A cough is a very common symptom of various upper and lower respiratory tract infections. It is a reflex response to mechanical, chemical, or inflammatory irritation of the tracheobronchial tree, which is conveyed by sensory neurons in the airways reflexly through neurons present in the brainstem. Antitussives, also known as cough suppressants, are widely used to relieve the symptoms of cough. Cough suppressant works by reducing the activity of cough reflex and suppresses the urge to cough. Dextromethorphan and Codeine are the two most common cough suppressant drugs widely used in the treatment of cough.

Frequent approvals and launch of new cough suppressant drugs and high prevalence of cough is expected to drive the market growth

In March 2018, Perrigo Company plc. received the FDA approval for the brand OTC equivalent of Mucinex DM Maximum Strength (Guaifenesin and Dextromethorphan Hydrobromide Extended-release Tablets, 1200 mg/60 mg). Mucinex DM Maximum Strength is indicated to control coughs and to break up mucus, making coughs more productive. Approval and launch of such new drugs in the market is expected to drive the cough suppressant drugs market growth over the forecast period.

High prevalence of cough is also expected to be a major factor for rising demand for cough suppressant drugs, which drives the market growth. For instance, according to the data published by the National Center for Biotechnology Information in 2014, cough is the most common reason for visits to primary care physicians globally, accounting for around 8% of all consultations. According to the same source, the annual prevalence of cough in the general population is reported as approximately 10–33% globally.

The global cough suppressant drugs market size was valued at US$ 1100.4 Mn in 2017 and is expected to witness a CAGR of 3.7% during the forecast period (2018 – 2026).

North America is expected to hold dominant position, owing to frequent approvals of new cough suppressant drugs by FDA

North America cough suppressant market is expected to show good growth over the forecast period, owing to frequent approvals to novel drugs by the FDA. For instance, in 2015, Vernalis plc and Tris Pharma Inc. received the U.S. Food and Drug Administration (FDA) approval for the New Drug Application (NDA) for Tuzistra XR (codeine polistirex and chlorpheniramine polistirex) extended-release oral suspension, CIII (DEA Schedule III). Tuzistra XR is a codeine-based extended-release oral suspension for cough-cold treatment.

Figure 1. Global Cough Suppressant Drugs Market Share (%) Analysis, By Region, 2026

Source: Coherent Market Insights Analysis (2017)

Key players in the market are involved in strategic mergers and partnerships, in order to develop, manufacture, and sell novel cough suppressant drugs and to gain major market share.

For instance, in 2015, Tris Pharma, Inc. entered into a license, supply, and distribution agreement with Pfizer Consumer Healthcare (a part of Pfizer Inc.). According to the agreement, Pfizer Consumer Healthcare will commercialize Tris’ extended release dextromethorphan cough syrup under the Robitussin Brand. In exchange, Tris will provide the U.S. branded rights to its protected intellectual property for an extended release dextromethorphan formulation to Pfizer Consumer Healthcare and Tris will receive an upfront payment, milestone payments, and sales-based royalties.

Figure 2. Global Cough Suppressant Drugs Market Share (%) Analysis, By Distribution Channel, 2026

cough suppressant drugs market fig 2

Various new players are entering lucrative cough suppressant drugs market by partnering with other manufacturers. For instance, in November 2018, Aytu BioScience, Inc., a specialty pharmaceutical company, entered into the cough suppressant drugs market with an exclusive license of FDA-approved Tuzistra XR from Tris Pharma Inc. Along with Tuzistra XR, Aytu BioScience, Inc. also has a licensed complementary antitussive product with pending FDA approval.

However, stringent regulations against the use of cough suppressant is expected to affect the global cough suppressant drugs market growth over the forecast period.

For instance, in February 2018, the Therapeutic Goods Administration reclassified codeine as prescription only medicine in Australia, which was previously available as over-the-counter medication. This reclassification was made, as regular use of medicines containing codeine may lead to its addiction.

In January 2018, the U.S. Food and Drug Administration made safety labeling changes to limit the use of codeine or hydrocodone containing prescription opioid cough and cold medicines in children younger than 18 years old to protect kids from serious risks of opioid ingredients containing cough treatment drugs. After the safety labeling changes, these products will no longer be indicated for treatment of cough in pediatric population and will be labeled for use only in adults aged 18 years and older.

Key players operating in the global cough suppressant drugs market include Perrigo Company plc, Vernalis plc, Tris Pharma Inc., Pfizer Inc., Aytu BioScience, Inc., Acella Pharmaceuticals LLC, Mayne Pharma Inc., Taro Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd, and GlaxoSmithKline plc.

A cough is a most common symptom of various upper and lower respiratory tract infections. It affects a large proportion of the population leading them to seek medical attention. According to the data published by Journal of the Association of Physicians of India in 2016, cough was identified as the sixth most common reason for hospital outpatient department visits. Cough suppressants, also known as antitussives, are medications that help to suppress cough. Some of the examples of cough suppressants are Dextromethorphan, Codeine, Noscapine, Butamirate, Benzonatate, and Pholcodine. Dextromethorphan and Codeine are the most common and widely used cough suppressant in market.

Market Dynamics

Frequent launch of new cough suppressants in the market by key players is expected to drive the cough suppressant drugs market growth over the forecast period. For instance, in March 2018, Perrigo Company plc. received the FDA approval for the brand OTC equivalent of Mucinex DM Maximum Strength (Guaifenesin and Dextromethorphan Hydrobromide Extended-release Tablets, 1200 mg/60 mg). Mucinex DM Maximum Strength is indicated to control coughs and to break up mucus, making coughs more productive.

Various key players in the market are conducting research and are evaluating safety and efficacy of various drugs for the treatment of cough. Such initiatives taken by companies is expected to lead to the development of new cough suppressant drugs.

For instance, CSPC ZhongQi Pharmaceutical Technology Co., Ltd. is evaluating the efficacy and safety of benzonatate soft capsules for improving adult cough symptoms, wherein the study is currently (2018) under phase 3 clinical trial.

Moreover, high prevalence of cough is expected to increase the demand for cough suppressant drugs, thereby driving the market growth. For instance, according to the study published by the National Center for Biotechnology Information in 2013, cough is a very common condition and around 12% of the people in Britain experience chronic cough, daily or weekly.

Key features of the study:

  • This report provides in-depth analysis of cough suppressant drugs market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by leading players
  • It profiles leading players in the global cough suppressant drugs market  based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Perrigo Company plc, Vernalis plc, Tris Pharma Inc., Pfizer Inc., Aytu BioScience, Inc., Acella Pharmaceuticals LLC, Mayne Pharma Inc., Taro Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd, and GlaxoSmithKline plc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global cough suppressant drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cough suppressant drugs market

Detailed Segmentation:

  • Global Cough Suppressant Drugs Market, By Disease Type :
    • Dry Cough
    • Wet Cough
  • Global Cough Suppressant Drugs Market, By Drug Type :
    • Dextromethorphan
    • Codeine
    • Noscapine
    • Butamirate
    • Benzonatate
    • Pholcodine
    • Others
  • Global Cough Suppressant Drugs Market, By Age Group:
    • Pediatric
    • Adult
  • Global Cough Suppressant Drugs Market, By Dosage Form:
    • Syrup
    • Tablet
    • Others
  • Global Cough Suppressant Drugs Market, By Distribution Channel:
    • Hospital
    • Retail Pharmacy
    • Online Pharmacy
    • Others
  • Global Cough Suppressant Drugs Market, By Region:
    • North America
      • By Disease Type :
        • Dry Cough
        • Wet Cough
      • By Drug Type:
        • Dextromethorphan
        • Codeine
        • Noscapine
        • Butamirate
        • Benzonatate
        • Pholcodine
        • Others
      • By Product Type
        • Over-the-counter (OTC)
        • Prescription Drug
      • By Age Group
        • Pediatric
        • Adult
      • By Dosage Form
        • Syrup
        • Tablet
        • Others
      • By Distribution Channel
        • Hospital
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Disease Type :
        • Dry Cough
        • Wet Cough
      • By Drug Type:
        • Dextromethorphan
        • Codeine
        • Noscapine
        • Butamirate
        • Benzonatate
        • Pholcodine
        • Others
      • By Product Type
        • Over-the-counter (OTC)
        • Prescription Drug
      • By Age Group
        • Pediatric
        • Adult
      • By Dosage Form
        • Syrup
        • Tablet
        • Others
      • By Distribution Channel
        • Hospital
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Disease Type :
        • Dry Cough
        • Wet Cough
      • By Drug Type:
        • Dextromethorphan
        • Codeine
        • Noscapine
        • Butamirate
        • Benzonatate
        • Pholcodine
        • Others
      • By Product Type
        • Over-the-counter (OTC)
        • Prescription Drug
      • By Age Group
        • Pediatric
        • Adult
      • By Dosage Form
        • Syrup
        • Tablet
        • Others
      • By Distribution Channel
        • Hospital
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Disease Type :
        • Dry Cough
        • Wet Cough
      • By Drug Type:
        • Dextromethorphan
        • Codeine
        • Noscapine
        • Butamirate
        • Benzonatate
        • Pholcodine
        • Others
      • By Product Type
        • Over-the-counter (OTC)
        • Prescription Drug
      • By Age Group
        • Pediatric
        • Adult
      • By Dosage Form
        • Syrup
        • Tablet
        • Others
      • By Distribution Channel
        • Hospital
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • By Disease Type :
        • Dry Cough
        • Wet Cough
      • By Drug Type:
        • Dextromethorphan
        • Codeine
        • Noscapine
        • Butamirate
        • Benzonatate
        • Pholcodine
        • Others
      • By Product Type
        • Over-the-counter (OTC)
        • Prescription Drug
      • By Age Group
        • Pediatric
        • Adult
      • By Dosage Form
        • Syrup
        • Tablet
        • Others
      • By Distribution Channel
        • Hospital
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Disease Type :
        • Dry Cough
        • Wet Cough
      • By Drug Type:
        • Dextromethorphan
        • Codeine
        • Noscapine
        • Butamirate
        • Benzonatate
        • Pholcodine
        • Others
      • By Product Type
        • Over-the-counter (OTC)
        • Prescription Drug
      • By Age Group
        • Pediatric
        • Adult
      • By Dosage Form
        • Syrup
        • Tablet
        • Others
      • By Distribution Channel
        • Hospital
        • Retail Pharmacy
        • Online Pharmacy
        • Others
      • By Country:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Perrigo Company plc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Vernalis plc.
    • Tris Pharma Inc.
    • Pfizer Inc.
    • Aytu BioScience, Inc.
    • Acella Pharmaceuticals LLC
    • Mayne Pharma Inc.
    • Taro Pharmaceutical Industries Ltd.
    • Amneal Pharmaceuticals LLC
    • Aurobindo Pharma Ltd.
    • GlaxoSmithKline plc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Disease Type
      • Market Snippet, By Drug Type
      • Market Snippet, By Product Type
      • Market Snippet, By Age Group
      • Market Snippet, By Dosage Form
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Novel Product Launch/Approval
    • Merger-Acquisition Scenario
    • PEST Analysis
    • PORTER’s Analysis
    • Regulatory Scenario
    • Reimbursement Scenario
    • Epidemiology
  4. Global Cough Suppressant Drugs Market, By Disease Type, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Dry Cough
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Wet Cough
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  5. Global Cough Suppressant Drugs Market, By Drug Type, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Dextromethorphan
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Codeine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Noscapine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Butamirate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Benzonatate
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Pholcodine
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  6. Global Cough Suppressant Drugs Market, By Product Type, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Over-the-counter (OTC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Prescription Drug
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  7. Global Cough Suppressant Drugs Market, By Age Group, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Pediatric
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Adult
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  8. Global Cough Suppressant Drugs Market, By Distribution Channel, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017–2026
      • Segment Trends
    • Hospital
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Retail Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Online Pharmacy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
  9. Global Cough Suppressant Drugs Market, By Region, 2016 – 2026 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Disease Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Drug Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Age Group, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Dosage Form, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Perrigo Company plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Vernalis plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Tris Pharma Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Aytu BioScience, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Acella Pharmaceuticals LLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Mayne Pharma Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Taro Pharmaceutical Industries Ltd
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Amneal Pharmaceuticals LLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Aurobindo Pharma Ltd
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GlaxoSmithKline plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  11. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 42 market data tables and 40 figures on “Cough Suppressant Drugs Market - Global forecast to 2026”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.